CIK 0001061983 · Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 943291317
- Phone
- (650) 624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- 4 Planned sale Director sold 20,000 shares at $38.46 ($769,200)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 3,190 shares at $38.66 ($123,325)
- 4 Grant or award Director acquired 551 shares (grant or award)
- 4 Grant or award Director acquired 324 shares (grant or award)
- 4 Grant or award Director acquired 324 shares (grant or award)
- 4 Grant or award Director acquired 162 shares (grant or award)
- 4 Grant or award Director acquired 162 shares (grant or award)
- 144 Insider Sale of Securities
- 4 Planned sale President & CEO sold 5,000 shares at $36.77 ($183,850)
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4 Planned sale EVP Research & Development sold 2,000 shares at $36.18 ($72,360)
- 144 Insider Sale of Securities
- 4 Planned sale EVP, Chief Commercial Officer sold 2,886 shares at $35.78 ($103,261)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 450 shares at $39.43 ($17,744)
- 4 Planned sale President & CEO sold 15,000 shares at $40.75 ($611,250)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Gift EVP Research & Development gave 200 shares (gift)
Page 15 of 127 · 2,534 filings